Medicine · 2018
Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion: A case report.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Huang Jing, Yu Yiming, Lin Wei, Zhang Dandan, Deng Zaichun, Ding Qunli
Аннотация
RATIONALE: Eosinophilic pleural effusion (EPE) is an eosinophil count ≥10% in pleural effusion, which is a rare condition in drug therapy.
PATIENT CONCERNS: We describe the case of a 70-year-old Alzheimer patient who was taking olanzapine for 2 months for the treatment of depression, and developed peripheral eosinophilia and bilateral EPE.
DIAGNOSES: Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion was diagnosed.
INTERVENTIONS: Olanzapine was discontinued, and repeated drainage of fluid from the pleural cavity was performed.
OUTCOMES: All symptoms-as well as the EPE-were resolved 6 months later.
LESSONS: This case is a reminder that olanzapine may be a potential agent for EPE, and that this should be considered in clinical practice.
PATIENT CONCERNS: We describe the case of a 70-year-old Alzheimer patient who was taking olanzapine for 2 months for the treatment of depression, and developed peripheral eosinophilia and bilateral EPE.
DIAGNOSES: Olanzapine-induced peripheral eosinophilia and eosinophilic pleural effusion was diagnosed.
INTERVENTIONS: Olanzapine was discontinued, and repeated drainage of fluid from the pleural cavity was performed.
OUTCOMES: All symptoms-as well as the EPE-were resolved 6 months later.
LESSONS: This case is a reminder that olanzapine may be a potential agent for EPE, and that this should be considered in clinical practice.